Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.6B |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$791M |
| 3 |
NIO
NIO
|
+$766M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$680M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$615M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.5B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$863M |
| 3 |
Alibaba
BABA
|
+$628M |
| 4 |
United States Oil Fund
USO
|
+$494M |
| 5 |
ExxonMobil
XOM
|
+$444M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.49% |
| 2 | Technology | 2.12% |
| 3 | Consumer Discretionary | 1.75% |
| 4 | Communication Services | 1.11% |
| 5 | Financials | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
PagerDuty
PD
$1.09B
| $8.54M | ﹤0.01% |
212,282
+147,587
| +228% | +$6.74M |
|
2977
Revolution Medicines
RVMD
$44.6B
| $8.53M | ﹤0.01% |
185,951
+171,148
| +1,156% | +$7.67M |
|
2978
CALL
Vertiv
VRT
$99B
| $8.53M | ﹤0.01% |
426,500
+176,400
| +71% | +$3.56M |
|
2979
US Foods
USFD
$23.2B
| $8.53M | ﹤0.01% |
+223,721
| New | +$8.09M |
|
2980
Perion Network
PERI
$382M
| $8.53M | ﹤0.01% |
476,296
+240,141
| +102% | +$4.34M |
|
2981
Kimberly-Clark
KMB
$36.4B
| $8.51M | ﹤0.01% |
61,219
+14,543
| +31% | +$1.93M |
|
2982
PUT
World Acceptance Corp
WRLD
$878M
| $8.51M | ﹤0.01% |
65,600
+62,400
| +1,950% | +$8.21M |
|
|
PRPB
2983
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
| $8.51M | ﹤0.01% |
863,021
+845,307
| +4,772% | +$8.86M |
|
2984
iShares Core S&P US Growth ETF
IUSG
$33.5B
| $8.5M | ﹤0.01% |
93,664
+74,164
| +380% | +$6.68M |
|
2985
CALL
Funko
FNKO
$398M
| $8.5M | ﹤0.01% |
+432,000
| New | +$6.03M |
|
|
SGI
2986
Somnigroup International
SGI
$13.5B
| $8.5M | ﹤0.01% |
232,409
+128,535
| +124% | +$4.16M |
|
2987
CALL
Wingstop
WING
$3.09B
| $8.49M | ﹤0.01% |
66,800
-19,600
| -23% | -$2.76M |
|
2988
PUT
Axsome Therapeutics
AXSM
$10.4B
| $8.49M | ﹤0.01% |
150,000
+11,500
| +8% | +$809K |
|
2989
CALL
Warner Music
WMG
$14.7B
| $8.49M | ﹤0.01% |
247,300
+127,100
| +106% | +$4.55M |
|
2990
CALL
McCormick & Company Non-Voting
MKC
$14.9B
| $8.49M | ﹤0.01% |
95,200
-34,800
| -27% | -$3.1M |
|
2991
CALL
Zions Bancorporation
ZION
$9.89B
| $8.49M | ﹤0.01% |
154,400
-94,100
| -38% | -$4.85M |
|
2992
PUT
Motorola Solutions
MSI
$80.4B
| $8.48M | ﹤0.01% |
45,100
+100
| +0.2% | +$17.8K |
|
2993
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.74B
| $8.48M | ﹤0.01% |
58,816
+29,912
| +103% | +$4.3M |
|
|
KNDI
2994
PUT
Kandi Technologies Group
KNDI
$61.9M
| $8.48M | ﹤0.01% |
1,356,800
+220,200
| +19% | +$1.69M |
|
|
GBT
2995
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $8.48M | ﹤0.01% |
208,100
-40,900
| -16% | -$1.88M |
|
2996
CALL
ACM Research
ACMR
$5.18B
| $8.47M | ﹤0.01% |
314,700
+67,500
| +27% | +$2.23M |
|
2997
PUT
M&T Bank
MTB
$34.3B
| $8.47M | ﹤0.01% |
55,900
-23,200
| -29% | -$3.42M |
|
|
NARI
2998
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $8.47M | ﹤0.01% |
+79,206
| New | +$8.22M |
|
2999
ARK Genomic Revolution ETF
ARKG
$1.88B
| $8.47M | ﹤0.01% |
95,419
+54,257
| +132% | +$5.38M |
|
3000
CALL
Charles River Laboratories
CRL
$13.9B
| $8.46M | ﹤0.01% |
29,200
-45,100
| -61% | -$12.5M |
|
Similar funds
Jeff Yass's Q1 2021 Portfolio in Review
As of Q1 2021, Jeff Yass held 13,312 positions worth $634B, up 3.5% from $612B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2021 filing shows 2,365 new, 5,232 increased, 4,447 reduced and 1,143 closed positions. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 480,790 shares worth $65.1M. The largest sale was Apple, an estimated $2.5B.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2021 buy was iShares 20+ Year Treasury Bond ETF: 480,790 shares worth $65.1M.
- Jeff Yass added most to Amazon in Q1 2021, an estimated $1.6B increase.
- Jeff Yass's biggest Q1 2021 reduction was Apple, cutting an estimated $2.5B.
- Jeff Yass fully exited Sina Corp in Q1 2021, selling an estimated $170M.
- Jeff Yass's ten largest holdings make up 28% of its $634B portfolio in Q1 2021.
- Jeff Yass opened 2,365 new positions and closed 1,143 in Q1 2021.
- Jeff Yass's portfolio value rose 3.5% quarter-over-quarter to $634B.
Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.